Vitality Watch

Dossier pubmed review 07-sep-2026
Narrative review or expert overview without new data

Rethinking Apathy and Gait: Clinical Implications for Dementia and Integrated Care.

Key claim: Apathy and gait slowing serve as early, observable clinical markers that frequently precede overt dementia and can enhance screening and integrated care strategies.

Abstract

There is increasing recognition that a broader array of biological changes may contribute to the clinical expression of cognitive decline. As such, an emerging and often overlooked consideration in dementia is apathy, gait dysfunction, motoric-cognitive risk syndrome, and their interplay. Broadly, apathy, gait dysfunction, and motoric-cognitive risk may reflect changes across multiple physiological and neural systems acting as clinical markers bridging normal aging and overt dementia, thereby offering a framework to better understand and monitor dementia risk, management, and prognosis. This article synthesizes some key findings in this emerging field, highlighting their relevance to integrated screening and intervention strategies. The authors emphasize the clinical importance of recognizing apathy and gait slowing as early, observable features that often precede overt cognitive impairment and are commonly encountered across routine clinical settings.

Why this matters

Apathy and gait slowing serve as early, observable clinical markers that frequently precede overt dementia and can enhance screening and integrated care strategies.

Source

Link

Briefing card

Rethinking Apathy and Gait: Clinical Implications for Dementia and Integrated Care.
Stage: review · pubmed · 07-sep-2026

Apathy and gait slowing serve as early, observable clinical markers that frequently precede overt dementia and can enhance screening and integrated care strategies.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.jamda.2026.106453

build build 880 · 2bcef25 · 2026-11-18